⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14617885 | 0.95 | SCN9A (0.30) | — | |
| SCHEMBL16090897 | 0.87 | AR (0.31) | — | |
| SCHEMBL1670051 | 0.87 | — | — | |
| SCHEMBL10177180 | 0.82 | SLC5A2 (0.33) | — | |
| SCHEMBL10228336 | 0.81 | — | — | |
| SCHEMBL14617884 | 0.81 | SLC5A2 (0.33) | — | |
| SCHEMBL16727633 | 0.80 | SLC5A2 (0.35) | — | |
| SCHEMBL10177146 | 0.80 | SLC5A2 (0.35) | — | |
| SCHEMBL16090896 | 0.75 | SLC5A2 (0.36) | — | |
| SCHEMBL18522242 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150141354-A1 | GLYCOSIDE DERIVATIVES AND USES THEREOF | NOVARTIS AG (CH) | 2015-05-21 | — | — | US | disclosed |
| US-8163704-B2 | Glycoside derivatives and uses thereof | NOVARTIS AG (CH) | 2012-04-24 | — | — | US | disclosed |
| US-20110171159-A1 | Glycoside Derivatives and Uses Thereof | NOVARTIS AG (CH) | 2011-07-14 | — | — | US | disclosed |